Market Newsdesk

STAMFORD, Conn., Nov. 16, 2020 (GLOBE NEWSWIRE) — New neuroscientific coaching techniques can help executives shape a corporate culture based on emotional and conversational agility and nurture high-performing teams that embrace continuous change, say experts with Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm.

“Near-universal levels of anxiety and uncertainty brought on by the pandemic, social unrest and economic upheaval have organizations and their employees on an emotional roller coaster,” said Missy Lawrence-Johnston, ISG principal consultant, Organizational Change Management. “For the many companies making all the right technological moves toward digital transformation but not getting the expected results, it may be time to look at the human side of digital.”

Lawrence-Johnston will be joined by David Christie, group vice president and head of digital strategy implementation for global biotech company CSL Behring, and agile enterprise expert Ola Chowning, ISG partner, Digital Strategy and Solutions, to discuss how to apply brain science to become a more effective product and technology leader, in the next ISG Smartalks™ webinar, “The Modern Digital Leader: Cultural Competency & Humility,” Thursday, November 19, at 11 a.m., U.S. Eastern Time.

ISG works with CSL Behring and other enterprises to apply brain science to help manage risks associated with the human side of digital and dramatically reduce the amount of time it takes for a workforce to rebound from major disruption. Neuroscientific training and tools can help businesses thrive by supporting virtual leadership, diversity awareness, communications around sensitive messages and approaches to inspire action in others, even during massive shifts, such as the recent shift to a virtual workforce.

“Leaders who apply neuroscience, the psychology of human dynamics and empathy to digital transformation can create a paradigm that fosters resilience and adaptability,” Chowning said. “Such approaches can deactivate employee fight-flight-or-freeze triggers and boost organizational effectiveness.”

Chowning said coaching designed specifically to support virtual and mindful leadership, coupled with cultural and behavioral assessments, can “lead to business structures that can handle whatever the future may bring.”

To register for the ISG Smartalks™ webinar, visit the event website.

About ISG

ISG (Information Services Group) (Nasdaq: III) is a leading global technology research and advisory firm. A trusted business partner to more than 700 clients, including more than 75 of the world’s top 100 enterprises, ISG is committed to helping corporations, public sector organizations, and service and technology providers achieve operational excellence and faster growth. The firm specializes in digital transformation services, including automation, cloud and data analytics; sourcing advisory; managed governance and risk services; network carrier services; strategy and operations design; change management; market intelligence and technology research and analysis. Founded in 2006, and based in Stamford, Conn., ISG employs more than 1,300 digital-ready professionals operating in more than 20 countries—a global team known for its innovative thinking, market influence, deep industry and technology expertise, and world-class research and analytical capabilities based on the industry’s most comprehensive marketplace data. For more information, visit www.isg-one.com.

# # #

Will Thoretz
Information Services Group, Inc. 
+1 203 517 3119
[email protected]

Jim Baptiste
Matter Communications for ISG
+1 978 518 4527
[email protected]

BRISBANE, Calif. and ST. LOUIS, Nov. 16, 2020 (GLOBE NEWSWIRE) — Arch Oncology, Inc., a clinical-stage immuno-oncology company focused on the discovery and development of anti-CD47 antibody therapies, today announced the appointment of Ronald Krasnow, Esq. as Chief Operating Officer. In this newly created position, Mr. Krasnow will report to Julie Hambleton, M.D., Arch Oncology’s Interim President and Chief Executive Officer.

“Ron is a legal and strategy executive with a unique breadth of experience helping lead companies through periods of growth and transition,” said Julie Hambleton, M.D., Interim President and Chief Executive Officer of Arch Oncology. “Over his career, he has led important strategic initiatives and transactions, built critical infrastructure, and rolled up his sleeves to get the job done. 2021 will be a transformational year for Arch Oncology, with multiple clinical trials for AO-176 advancing for patients in solid tumors and hematologic malignancies. We are thrilled to have Ron join our team, and I look forward to having him as a thought partner in the exciting years ahead at Arch Oncology.”

Ronald Krasnow added, “I am excited to join this team as I believe in the important mission to develop a potential best-in-class anti-CD47 therapy for patients living with cancer. I look forward to leveraging my experience to be part of this team’s collective effort to drive Arch Oncology’s development programs forward to help patients.”

Ronald Krasnow, Esq. has over twenty years of experience serving on executive management teams for life-science and technology companies. Before joining Arch Oncology, he served as General Counsel and Chief Compliance Officer for Menlo Therapeutics, Inc. Previously, he was Chief Strategy Officer, General Counsel, and Secretary for Kinestral Technologies, Inc. In addition, he worked at Relypsa for a decade, serving as Senior Vice President and General Counsel as the company developed and commercialized Veltassa^® and subsequently merged with Vifor Pharma. Earlier, he was Senior Vice President, Intellectual Property for Symyx Technologies, Inc., an attorney in private practice for a law firm, and Patent Examiner at the U.S. Patent and Trademark Office. He earned a B.S. in Engineering from the University of Michigan and a J.D. from George Washington University School of Law.

About
Arch Oncology

Arch Oncology, Inc. is a privately-held, clinical-stage immuno-oncology company focused on the discovery and development of potential best-in-class antibody therapies for the treatment of patients with solid tumors and hematologic malignancies. The Company’s next-generation anti-CD47 antibodies are highly differentiated, with the potential to improve upon the safety and efficacy profile relative to other agents in this class. Arch Oncology’s lead product candidate AO-176 is in Phase 1/2 clinical trials for the treatment of patients with select solid tumors and with multiple myeloma, both as monotherapy and in combination with standard therapies. In addition, the Company is advancing a pipeline of antibody programs for the treatment of cancer. For more information please visit www.archoncology.com.

Contact:
Amy Figueroa, CFA
For Arch Oncology
[email protected]

ꟷ
AMD Instinct™ MI100 accelerators
revolutionize
high-performance computing (
HPC)
and AI
with
industry-leading
compute
performance
ꟷ

ꟷ
First
GPU
a
ccelerator
with new
AMD
CDNA architecture
engineered
for the exascale er
a
ꟷ

SANTA CLARA, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) —  AMD (NASDAQ: AMD) today announced the new AMD Instinct™ MI100 accelerator – the world’s fastest HPC GPU and the first x86 server GPU to surpass the 10 teraflops (FP64) performance barrier.¹ Supported by new accelerated compute platforms from Dell, Gigabyte, HPE, and Supermicro, the MI100, combined with AMD EPYC^TM CPUs and the ROCm™ 4.0 open software platform, is designed to propel new discoveries ahead of the exascale era.

Built on the new AMD CDNA architecture, the AMD Instinct MI100 GPU enables a new class of accelerated systems for HPC and AI when paired with 2^nd Gen AMD EPYC processors. The MI100 offers up to 11.5 TFLOPS of peak FP64 performance for HPC and up to 46.1 TFLOPS peak FP32 Matrix performance for AI and machine learning workloads². With new AMD Matrix Core technology, the MI100 also delivers a nearly 7x boost in FP16 theoretical peak floating point performance for AI training workloads compared to AMD’s prior generation accelerators.³

“Today AMD takes a major step forward in the journey toward exascale computing as we unveil the AMD Instinct MI100 – the world’s fastest HPC GPU,” said Brad McCredie, corporate vice president, Data Center GPU and Accelerated Processing, AMD. “Squarely targeted toward the workloads that matter in scientific computing, our latest accelerator, when combined with the AMD ROCm open software platform, is designed to provide scientists and researchers a superior foundation for their work in HPC.”

Open
Software
Platform
for the Exascale Era

The AMD ROCm developer software provides the foundation for exascale computing. As an open source toolset consisting of compilers, programming APIs and libraries, ROCm is used by exascale software developers to create high performance applications. ROCm 4.0 has been optimized to deliver performance at scale for MI100-based systems. ROCm 4.0 has upgraded the compiler to be open source and unified to support both OpenMP® 5.0 and HIP. PyTorch and Tensorflow frameworks, which have been optimized with ROCm 4.0, can now achieve higher performance with MI100^7,8. ROCm 4.0 is the latest offering for HPC, ML and AI application developers which allows them to create performance portable software.

“We’ve received early access to the MI100 accelerator, and the preliminary results are very encouraging. We’ve typically seen significant performance boosts, up to 2-3x compared to other GPUs,” said Bronson Messer, director of science, Oak Ridge Leadership Computing Facility. “What’s also important to recognize is the impact software has on performance. The fact that the ROCm open software platform and HIP developer tool are open source and work on a variety of platforms, it is something that we have been absolutely almost obsessed with since we fielded the very first hybrid CPU/GPU system.”

Key capabilities and features of the AMD Instinct MI100 accelerator include:

• All-New
  AMD
  CDNA Architecture- Engineered to power AMD GPUs for the exascale era and at the heart of the MI100 accelerator, the AMD CDNA architecture offers exceptional performance and power efficiency
• Leading FP64
  and FP32
  Performance for HPC Workloads – Delivers industry leading 11.5 TFLOPS peak FP64 performance and 23.1 TFLOPS peak FP32 performance, enabling scientists and researchers across the globe to accelerate discoveries in industries including life sciences, energy, finance, academics, government, defense and more.¹
• All-New Matrix Core Technology for
  HPC and AI – Supercharged performance for a full range of single and mixed precision matrix operations, such as FP32, FP16, bFloat16, Int8 and Int4, engineered to boost the convergence of HPC and AI.
• 2
  
  ^nd
  
  Gen
  AMD Infinity Fabric™ Technology
  – Instinct MI100 provides ~2x the peer-to-peer (P2P) peak I/O bandwidth over PCIe® 4.0 with up to 340 GB/s of aggregate bandwidth per card with three AMD Infinity Fabric™ Links.⁴ In a server, MI100 GPUs can be configured with up to two fully-connected quad GPU hives, each providing up to 552 GB/s of P2P I/O bandwidth for fast data sharing.⁴
• Ultra-Fast HBM2 Memory– Features 32GB High-bandwidth HBM2 memory at a clock rate of 1.2 GHz and delivers an ultra-high 1.23 TB/s of memory bandwidth to support large data sets and help eliminate bottlenecks in moving data in and out of memory.⁵
• Support for
  Industry’s Latest PCIe® Gen 4.0 – Designed with the latest PCIe Gen 4.0 technology support providing up to 64GB/s peak theoretical transport data bandwidth from CPU to GPU.⁶

Available Server Solutions

The AMD Instinct MI100 accelerators are expected by end of the year in systems from major OEM and ODM partners in the enterprise markets, including:

Dell

“Dell EMC PowerEdge servers will support the new AMD Instinct MI100, which will enable faster insights from data. This would help our customers achieve more robust and efficient HPC and AI results rapidly,” said Ravi Pendekanti, senior vice president, PowerEdge Servers, Dell Technologies. “AMD has been a valued partner in our support for advancing innovation in the data center. The high-performance capabilities of AMD Instinct accelerators are a natural fit for our PowerEdge server AI & HPC portfolio.”

Gigabyte
“We’re pleased to again work with AMD as a strategic partner offering customers server hardware for high performance computing,” said Alan Chen, assistant vice president in NCBU, GIGABYTE. “AMD Instinct MI100 accelerators represent the next level of high-performance computing in the data center, bringing greater connectivity and data bandwidth for energy research, molecular dynamics, and deep learning training. As a new accelerator in the GIGABYTE portfolio, our customers can look to benefit from improved performance across a range of scientific and industrial HPC workloads.”

Hewlett Packard Enterprise (HPE)

“Customers use HPE Apollo systems for purpose-built capabilities and performance to tackle a range of complex, data-intensive workloads across high-performance computing (HPC), deep learning and analytics,” said Bill Mannel, vice president and general manager, HPC at HPE. “With the introduction of the new HPE Apollo 6500 Gen10 Plus system, we are further advancing our portfolio to improve workload performance by supporting the new AMD Instinct MI100 accelerator, which enables greater connectivity and data processing, alongside the 2^nd Gen AMD EPYC™ processor. We look forward to continuing our collaboration with AMD to expand our offerings with its latest CPUs and accelerators.”

Supermicro
“We’re excited that AMD is making a big impact in high-performance computing with AMD Instinct MI100 GPU accelerators,” said Vik Malyala, senior vice president, field application engineering and business development, Supermicro. “With the combination of the compute power gained with the new CDNA architecture, along with the high memory and GPU peer-to-peer bandwidth the MI100 brings, our customers will get access to great solutions that will meet their accelerated compute requirements and critical enterprise workloads. The AMD Instinct MI100 will be a great addition for our multi-GPU servers and our extensive portfolio of high-performance systems and server building block solutions.”

MI100 Specifications

Compute Units	Stream Processors	FP64 TFLOPS (Peak)	FP32 TFLOPS (Peak)	FP32 Matrix TFLOPS (Peak)	FP16/FP16 Matrix TFLOPS (Peak)	INT4 | INT8 TOPS (Peak)	bFloat16 TFLOPS (Peak)	HBM2 ECC Memory	Memory Bandwidth
120	7680	Up to 11.5	Up to 23.1	Up to 46.1	Up to 184.6	Up to 184.6	Up to 92.3 TFLOPS	32GB	Up to 1.23 TB/s

Supporting Resources

• Learn more about AMD Instinct™ Accelerators
• Learn more about AMD HPC Solutions
• AMD HPC Solutions Hub
• Learn more about AMD CDNA
• Learn more about the AMD 2^nd Gen EPYC™ Processor
• Become a fan of AMD on Facebook
• Follow AMD on Twitter

About AMD

For more than 50 years AMD has driven innovation in high-performance computing, graphics and visualization technologies ― the building blocks for gaming, immersive platforms and the data center. Hundreds of millions of consumers, leading Fortune 500 businesses and cutting-edge scientific research facilities around the world rely on AMD technology daily to improve how they live, work and play. AMD employees around the world are focused on building great products that push the boundaries of what is possible. For more information about how AMD is enabling today and inspiring tomorrow, visit the AMD (NASDAQ: AMD) website, blog, Facebook and Twitter pages.

CAUTIONARY STATEMENT

This press release contains forward-looking statements concerning Advanced Micro Devices, Inc. (AMD) such as the features, functionality, performance, availability, timing and expected benefits of AMD products including the AMD Instinct™ MI100 accelerator, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward looking statements are commonly identified by words such as “would,” “may,” “expects,” “believes,” “plans,” “intends,” “projects” and other terms with similar meaning. Investors are cautioned that the forward-looking statements in this press release are based on current beliefs, assumptions and expectations, speak only as of the date of this press release and involve risks and uncertainties that could cause actual results to differ materially from current expectations. Such statements are subject to certain known and unknown risks and uncertainties, many of which are difficult to predict and generally beyond AMD’s control, that could cause actual results and other future events to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. Material factors that could cause actual results to differ materially from current expectations include, without limitation, the following: Intel Corporation’s dominance of the microprocessor market and its aggressive business practices; the ability of third party manufacturers to manufacture AMD’s products on a timely basis in sufficient quantities and using competitive technologies; expected manufacturing yields for AMD’s products; the availability of essential equipment, materials or manufacturing processes; AMD’s ability to introduce products on a timely basis with features and performance levels that provide value to its customers; global economic uncertainty; the loss of a significant customer; AMD’s ability to generate revenue from its semi-custom SoC products; the impact of the COVID-19 pandemic on AMD’s business, financial condition and results of operations; political, legal, economic risks and natural disasters; the impact of government actions and regulations such as export administration regulations, tariffs and trade protection measures; the impact of acquisitions, joint ventures and/or investments on AMD’s business, including the announced acquisition of Xilinx, and the failure to integrate acquired businesses; AMD’s ability to complete the Xilinx merger; the impact of the announcement and pendency of the Xilinx merger on AMD’s business; potential security vulnerabilities; potential IT outages, data loss, data breaches and cyber-attacks; uncertainties involving the ordering and shipment of AMD’s products; quarterly and seasonal sales patterns; the restrictions imposed by agreements governing AMD’s notes and the revolving credit facility; the competitive markets in which AMD’s products are sold; market conditions of the industries in which AMD products are sold; AMD’s reliance on third-party intellectual property to design and introduce new products in a timely manner; AMD’s reliance on third-party companies for the design, manufacture and supply of motherboards, software and other computer platform components; AMD’s reliance on Microsoft Corporation and other software vendors’ support to design and develop software to run on AMD’s products; AMD’s reliance on third-party distributors and add-in-board partners; the potential dilutive effect if the 2.125% Convertible Senior Notes due 2026 are converted; future impairments of goodwill and technology license purchases; AMD’s ability to attract and retain qualified personnel; AMD’s ability to generate sufficient revenue and operating cash flow or obtain external financing for research and development or other strategic investments; AMD’s indebtedness; AMD’s ability to generate sufficient cash to service its debt obligations or meet its working capital requirements; AMD’s ability to repurchase its outstanding debt in the event of a change of control; the cyclical nature of the semiconductor industry; the impact of modification or interruption of AMD’s internal business processes and information systems; compatibility of AMD’s products with some or all industry-standard software and hardware; costs related to defective products; the efficiency of AMD’s supply chain; AMD’s ability to rely on third party supply-chain logistics functions; AMD’s stock price volatility; worldwide political conditions; unfavorable currency exchange rate fluctuations; AMD’s ability to effectively control the sales of its products on the gray market; AMD’s ability to adequately protect its technology or other intellectual property; current and future claims and litigation; potential tax liabilities; and the impact of environmental laws, conflict minerals-related provisions and other laws or regulations. Investors are urged to review in detail the risks and uncertainties in AMD’s Securities and Exchange Commission filings, including but not limited to AMD’s Quarterly Report on Form 10-Q for the quarter ended September 26, 2020.

©2020 Advanced Micro Devices, Inc. All rights reserved. AMD, the AMD Arrow logo, EPYC, AMD Instinct, Infinity Fabric, ROCm and combinations thereof are trademarks of Advanced Micro Devices, Inc. The OpenMP name and the OpenMP logos are registered trademarks of the OpenMP Architecture Review Board. PCIe is a registered trademark of PCI-SIG Corporation. Python is a trademark of the Python Software Foundation. PyTorch is a trademark or registered trademark of PyTorch. TensorFlow, the TensorFlow logo and any related marks are trademarks of Google Inc. Other product names used in this publication are for identification purposes only and may be trademarks of their respective companies.
_______________________________

1. Calculations conducted by AMD Performance Labs as of Sep 18, 2020 for the AMD Instinct™ MI100 (32GB HBM2 PCIe® card) accelerator at 1,502 MHz peak boost engine clock resulted in 11.54 TFLOPS peak double precision (FP64), 46.1 TFLOPS peak single precision matrix (FP32), 23.1 TFLOPS peak single precision (FP32), 184.6 TFLOPS peak half precision (FP16) peak theoretical, floating-point performance. Published results on the NVidia Ampere A100 (40GB) GPU accelerator resulted in 9.7 TFLOPS peak double precision (FP64). 19.5 TFLOPS peak single precision (FP32), 78 TFLOPS peak half precision (FP16) theoretical, floating-point performance. Server manufacturers may vary configuration offerings yielding different results. MI100-03
2. Calculations performed by AMD Performance Labs as of Sep 3, 2020 on the AMD Instinct™ MI100 (32GB HBM2 PCIe® card) accelerator at 1,502 MHz peak engine clock resulted in 46.1 TFLOPS peak theoretical single precision (FP32 Matrix) Math floating-point performance. The Nvidia Ampere A100 (40GB) GPU accelerator published results are 19.5 TFLOPS peak single precision (FP32) floating-point performance. Nvidia results found at: https://www.nvidia.com/content/dam/en-zz/Solutions/Data-Center/nvidia-ampere-architecture-whitepaper.pdf. Server manufacturers may vary configuration offerings yielding different results. MI100-01
3. Calculations performed by AMD Performance Labs as of Sep 18, 2020 for the AMD Instinct™ MI100 accelerator at 1,502 MHz peak boost engine clock resulted in 184.57 TFLOPS peak theoretical half precision (FP16) and 46.14 TFLOPS peak theoretical single precision (FP32 Matrix) floating-point performance. The results calculated for Radeon Instinct™ MI50 GPU at 1,725 MHz peak engine clock resulted in 26.5 TFLOPS peak theoretical half precision (FP16) and 13.25 TFLOPS peak theoretical single precision (FP32 Matrix) floating-point performance. Server manufacturers may vary configuration offerings yielding different results. MI100-04
4. Calculations as of SEP 18th, 2020. AMD Instinct™ MI100 built on AMD CDNA technology accelerators supporting PCIe® Gen4 providing up to 64 GB/s peak theoretical transport data bandwidth from CPU to GPU per card. AMD Instinct™ MI100 accelerators include three Infinity Fabric™ links providing up to 276 GB/s peak theoretical GPU to GPU or Peer-to-Peer (P2P) transport rate bandwidth performance per GPU card. Combined with PCIe Gen4 support providing an aggregate GPU card I/O peak bandwidth of up to 340 GB/s. MI100s have three links: 92 GB/s * 3 links per GPU = 276 GB/s. Four GPU hives provide up to 552 GB/s peak theoretical P2P performance. Dual 4 GPU hives in a server provide up to 1.1 TB/s total peak theoretical direct P2P performance per server. AMD Infinity Fabric link technology not enabled: Four GPU hives provide up to 256 GB/s peak theoretical P2P performance with PCIe® 4.0. Server manufacturers may vary configuration offerings yielding different results. MI100-07
5. Calculations by AMD Performance Labs as of Oct 5th, 2020 for the AMD Instinct™ MI100 accelerator designed with AMD CDNA 7nm FinFET process technology at 1,200 MHz peak memory clock resulted in 1.2288 TFLOPS peak theoretical memory bandwidth performance. The results calculated for Radeon Instinct™ MI50 GPU designed with “Vega” 7nm FinFET process technology with 1,000 MHz peak memory clock resulted in 1.024 TFLOPS peak theoretical memory bandwidth performance. CDNA-04
6. Works with PCIe® Gen 4.0 and Gen 3.0 compliant motherboards. Performance may vary from motherboard to motherboard. Refer to system or motherboard provider for individual product performance and features.
7. Testing Conducted by AMD performance labs as of October 30th, 2020, on three platforms and software versions typical for the launch dates of the Radeon Instinct MI25 (2018), MI50 (2019) and AMD Instinct MI100 GPU (2020) running the benchmark application Quicksilver. MI100 platform (2020): Gigabyte G482-Z51-00 system comprised of Dual Socket AMD EPYC™ 7702 64-Core Processor, AMD Instinct™ MI100 GPU, ROCm™ 3.10 driver, 512GB DDR4, RHEL 8.2.  MI50 platform (2019): Supermicro® SYS-4029GP-TRT2 system comprised of Dual Socket Intel Xeon® Gold® 6132, Radeon Instinct™ MI50 GPU, ROCm 2.10 driver, 256 GB DDR4, SLES15SP1. MI25 platform (2018): Supermicro SYS-4028GR-TR2 system comprised of Dual Socket Intel Xeon CPU E5-2690, Radeon Instinct™ MI25 GPU, ROCm 2.0.89 driver, 246GB DDR4 system memory, Ubuntu 16.04.5 LTS. MI100-14
8. Testing Conducted by AMD performance labs as of October 30th, 2020, on three platforms and software versions typical for the launch dates of the Radeon Instinct MI25 (2018), MI50 (2019) and AMD Instinct MI100 GPU (2020) running the benchmark application TensorFlow ResNet 50 FP 16 batch size 128. MI100 platform (2020): Gigabyte G482-Z51-00 system comprised of Dual Socket AMD EPYC™ 7702 64-Core Processor, AMD Instinct™ MI100 GPU, ROCm™ 3.10 driver, 512GB DDR4, RHEL 8.2. MI50 platform (2019): Supermicro® SYS-4029GP-TRT2 system comprised of Dual Socket Intel Xeon® Gold® 6254, Radeon Instinct™ MI50 GPU, ROCm 3.0.6 driver, 338 GB DDR4, Ubuntu® 16.04.6 LTS. MI25 platform (2018): a Supermicro SYS-4028GR-TR2 system comprised of Dual Socket Intel Xeon CPU E5-2690, Radeon Instinct™ MI25 GPU, ROCm 2.0.89 driver, 246GB DDR4 system memory, Ubuntu 16.04.5 LTS. MI100-15

Contacts:
Gary Silcott
AMD Communications
+1 512-602-0889
[email protected]

Laura Graves
AMD Investor Relations
+1 408-749-5467
[email protected]

Leading Systems Providers Atos, Dell Technologies, Fujitsu,
GIGABYTE, Hewlett Packard Enterprise, Inspur, Lenovo, Quanta and Supermicro to Offer NVIDIA A100 Systems 
to World’s Industries

SANTA CLARA, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) — SC20—NVIDIA today unveiled the NVIDIA^® A100 80GB GPU — the latest innovation powering the NVIDIA HGX™ AI supercomputing platform — with twice the memory of its predecessor, providing researchers and engineers unprecedented speed and performance to unlock the next wave of AI and scientific breakthroughs.

The new A100 with HBM2e technology doubles the A100 40GB GPU’s high-bandwidth memory to 80GB and delivers over 2 terabytes per second of memory bandwidth. This allows data to be fed quickly to A100, the world’s fastest data center GPU, enabling researchers to accelerate their applications even faster and take on even larger models and datasets.

“Achieving state-of-the-art results in HPC and AI research requires building the biggest models, but these demand more memory capacity and bandwidth than ever before,” said Bryan Catanzaro, vice president of applied deep learning research at NVIDIA. “The A100 80GB GPU provides double the memory of its predecessor, which was introduced just six months ago, and breaks the 2TB per second barrier, enabling researchers to tackle the world’s most important scientific and big data challenges.”

The NVIDIA A100 80GB GPU is available in NVIDIA DGX™ A100 and NVIDIA DGX Station™ A100 systems, also announced today and expected to ship this quarter.

Leading systems providers Atos, Dell Technologies, Fujitsu, GIGABYTE, Hewlett Packard Enterprise, Inspur, Lenovo, Quanta and Supermicro are expected to begin offering systems built using HGX A100 integrated baseboards in four- or eight-GPU configurations featuring A100 80GB in the first half of 2021. 

Fueling Data-Hungry Workloads

Building on the diverse capabilities of the A100 40GB, the 80GB version is ideal for a wide range of applications with enormous data memory requirements.

For AI training, recommender system models like DLRM have massive tables representing billions of users and billions of products. A100 80GB delivers up to a 3x speedup, so businesses can quickly retrain these models to deliver highly accurate recommendations.

The A100 80GB also enables training of the largest models with more parameters fitting within a single HGX-powered server such as GPT-2, a natural language processing model with superhuman generative text capability. This eliminates the need for data or model parallel architectures that can be time consuming to implement and slow to run across multiple nodes.

With its multi-instance GPU (MIG) technology, A100 can be partitioned into up to seven GPU instances, each with 10GB of memory. This provides secure hardware isolation and maximizes GPU utilization for a variety of smaller workloads. For AI inferencing of automatic speech recognition models like RNN-T, a single A100 80GB MIG instance can service much larger batch sizes, delivering 1.25x higher inference throughput in production.

On a big data analytics benchmark for retail in the terabyte-size range, the A100 80GB boosts performance up to 2x, making it an ideal platform for delivering rapid insights on the largest of datasets. Businesses can make key decisions in real time as data is updated dynamically.

For scientific applications, such as weather forecasting and quantum chemistry, the A100 80GB can deliver massive acceleration. Quantum Espresso, a materials simulation, achieved throughput gains of nearly 2x with a single node of A100 80GB.

“Speedy and ample memory bandwidth and capacity are vital to realizing high performance in supercomputing applications,” said Satoshi Matsuoka, director at RIKEN Center for Computational Science. “The NVIDIA A100 with 80GB of HBM2e GPU memory, providing the world’s fastest 2TB per second of bandwidth, will help deliver a big boost in application performance.”

K
ey Features of A100 80GB

The A100 80GB includes the many groundbreaking features of the NVIDIA Ampere architecture:

• Third-Generation Tensor Cores: Provide up to 20x AI throughput of the previous Volta generation with a new format TF32, as well as 2.5x FP64 for HPC, 20x INT8 for AI inference and support for the BF16 data format.
• Larger, Faster HBM2e GPU Memory: Doubles the memory capacity and is the first in the industry to offer more than 2TB per second of memory bandwidth.
• MIG
  technology
  : Doubles the memory per isolated instance, providing up to seven MIGs with 10GB each.
• Structural Sparsity: Delivers up to a 2x speedup inferencing sparse models.
• Third-Generation NVL
  ink
  
  ^®
  
  and NVSwitch™: Provide twice the GPU-to-GPU bandwidth of the previous generation interconnect technology, accelerating data transfers to the GPU for data-intensive workloads to 600 gigabytes per second.

NVIDIA HGX AI Supercomputing Platform

The A100 80GB GPU is a key element in NVIDIA HGX AI supercomputing platform, which brings together the full power of NVIDIA GPUs, NVIDIA NVLink, NVIDIA InfiniBand networking and a fully optimized NVIDIA AI and HPC software stack to provide the highest application performance. It enables researchers and scientists to combine HPC, data analytics and deep learning computing methods to advance scientific progress.

Learn more about NVIDIA A100 80GB in the live NVIDIA SC20 Special Address at 3 p.m. PT today.

About NVIDIA

NVIDIA’s (NASDAQ: NVDA) invention of the GPU in 1999 sparked the growth of the PC gaming market, redefined modern computer graphics and revolutionized parallel computing. More recently, GPU deep learning ignited modern AI — the next era of computing — with the GPU acting as the brain of computers, robots and self-driving cars that can perceive and understand the world. More information at http://nvidianews.nvidia.com/.

For further information, contact:

Kristin Uchiyama
NVIDIA Corporation
+1-408-313-0448
[email protected]

Certain statements in this press release including, but not limited to, statements as to: the benefits, performance, features and abilities of the NVIDIA A100 80GB GPU and what it enables; the systems providers that will offer NVIDIA A100 systems and the timing for such availability; the A100 80GB GPU providing more memory and speed, and enabling researchers to tackle the world’s challenges; the availability of the NVIDIA A100 80GB GPU; memory bandwidth and capacity being vital to realizing high performance in supercomputing applications; the NVIDIA A100 providing the fastest bandwidth and delivering a boost in application performance; and the NVIDIA HGX supercomputing platform providing the highest application performance and enabling advances in scientific progress are forward-looking statements that are subject to risks and uncertainties that could cause results to be materially different than expectations. Important factors that could cause actual results to differ materially include: global economic conditions; our reliance on third parties to manufacture, assemble, package and test our products; the impact of technological development and competition; development of new products and technologies or enhancements to our existing product and technologies; market acceptance of our products or our partners’ products; design, manufacturing or software defects; changes in consumer preferences or demands; changes in industry standards and interfaces; unexpected loss of performance of our products or technologies when integrated into systems; as well as other factors detailed from time to time in the most recent reports NVIDIA files with the Securities and Exchange Commission, or SEC, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q. Copies of reports filed with the SEC are posted on the company’s website and are available from NVIDIA without charge. These forward-looking statements are not guarantees of future performance and speak only as of the date hereof, and, except as required by law, NVIDIA disclaims any obligation to update these forward-looking statements to reflect future events or circumstances.

© 2020 NVIDIA Corporation. All rights reserved. NVIDIA, the NVIDIA logo, NVIDIA DGX, NVIDIA DGX Station, NVIDIA HGX, NVLink and NVSwitch are trademark and/or registered trademarks of NVIDIA Corporation in the U.S. and other countries. All other trademarks and copyrights are the property of their respective owners. Features, pricing, availability, and specifications are subject to change without notice.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6faa9e70-5870-468d-a06a-eca0bcec2ccd

REDWOOD CITY, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) — Sumo Logic, (Nasdaq: SUMO) the pioneer in continuous intelligence, announced today that members of its management team will present at the following investor conferences:

• The RBC Capital Markets Global Technology, Internet, Media and Telecom Virtual Conference, November 18th at 1:20 PM Eastern Time
• The Jefferies Virtual Public Cloud Summit, November 30th at 1:00 PM Eastern Time
• The Morgan Stanley Future of App Development Conference, December 9th at 12:00 PM Eastern Time

Webcasts of these events will be available on the investor relations section of the company’s website at http://investor.sumologic.com.

About Sumo Logic

Sumo Logic Inc., (Nasdaq: SUMO), is the pioneer in continuous intelligence, a new category of software, which enables organizations of all sizes to address the data challenges and opportunities presented by digital transformation, modern applications, and cloud computing. The Sumo Logic Continuous Intelligence Platform™ automates the collection, ingestion, and analysis of application, infrastructure, security, and IoT data to derive actionable insights within seconds. More than 2,100 customers around the world rely on Sumo Logic to build, run, and secure their modern applications and cloud infrastructures. Only Sumo Logic delivers its platform as a true, multi-tenant SaaS architecture, across multiple use-cases, enabling businesses to thrive in the Intelligence Economy. For more information, visit www.sumologic.com.

Sumo Logic is a trademark or registered trademark of Sumo Logic in the United States and in foreign countries. All other company and product names may be trademarks or registered trademarks of their respective owners.

Any information regarding offerings, updates, functionality, or other modifications, including release dates, is subject to change without notice. The development, release, and timing of any offering, update, functionality, or modification described herein remains at the sole discretion of Sumo Logic, and should not be relied upon in making a purchase decision, nor as a representation, warranty, or commitment to deliver specific offerings, updates, functionalities, or modifications in the future.

Investor Relations Contact

Paul Thomas
Sumo Logic
[email protected]
(650) 214-3847

Media Contact

Melissa Liton
Sumo Logic
[email protected]
(650) 814-3882

• New
  in vitro
  data also
  demonstrates
  Brilacidin
  ’s
  anti-SARS-CoV-2 potency
  is
  unlikely to be
  impacted
  by
  mutations in different strains of the virus
  

WAKEFIELD, Mass., Nov. 16, 2020 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announces today that an overseas Clinical Trial Application (CTA) has been submitted to the governing health agency, with a U.S. Investigational New Drug (IND) application also to be submitted this week to the FDA. Both these submissions are part of final preparations for the Company’s multinational Phase 2 clinical trial of Brilacidin for COVID-19, which is on track to commence in 2020 upon gaining required approvals.

The randomized, double-blind, placebo-controlled, multi-center study is anticipated to enroll 120 hospitalized patients with COVID-19. Sufficient Brilacidin intravenous (IV) drug product has been manufactured to complete this trial, and potentially future COVID-19 trials, providing the Company with added flexibility as it develops Brilacidin for the treatment of COVID-19.

In other important news, the Company has been informed by researchers at George Mason University’s Regional Biocontainment Laboratory that new in vitro testing showed Brilacidin exerted similarly potent inhibition against two strains of SARS-CoV-2, the novel coronavirus responsible for COVID-19. These data suggest Brilacidin would likely not be susceptible to resistance developing due to SARS-CoV-2 mutations, unlike many other vaccines and antivirals currently in use and in development.

“Due to the rapid worldwide spread of the COVID-19 pandemic, the need for novel therapeutics to help control this disease has only increased,” commented Leo Ehrlich, Chief Executive Officer at Innovation Pharmaceuticals. “While we all hope for the expedient arrival of safe and effective COVID-19 vaccines, which is one part of the solution, the need for better therapeutics to treat this disease, including its different strains, also remains essential. Vaccines and therapeutics both will play integral roles in addressing the current COVID-19 pandemic and possible future viral pandemics. We are excited by Brilacidin’s potential to treat SARS-CoV-2 and look forward to the start of our upcoming clinical trial, as we continue to advance Brilacidin in the global fight against COVID-19.”

Brilacidin and COVID-19

Brilacidin is one of the few drugs targeting COVID-19 that has been tested in human trials (a total of 8) for other clinical indications, providing established safety and efficacy data on over 460 subjects, thereby potentially enabling it to rapidly help address the novel coronavirus crisis. Laboratory testing at independent laboratories supports Brilacidin’s antiviral ability to safely and potently inhibit SARS-CoV-2. In a human lung cell line, Brilacidin achieved a Selectivity Index of 426. A molecular screening study of 11,552 compounds also supports Brilacidin as a promising novel coronavirus treatment. Additional pre-clinical and clinical data support Brilacidin’s inhibition of IL-6, IL-1β, TNF-α and other pro-inflammatory cytokines and chemokines, which have been identified as central drivers in the worsening prognoses of hospitalized COVID-19 patients. Brilacidin’s robust antimicrobial properties might also help to fight secondary bacterial infections, which can co-present in up to 20 percent of COVID-19 patients. Collectively, these data support Brilacidin as a unique 3 in 1 combination—antiviral, immuno/anti-inflammatory, and antimicrobial—COVID-19 therapeutic candidate. A preprint supporting Brilacidin’s COVID-19 treatment potential can be downloaded on bioRxiv.org at the link below.

• Brilacidin, a COVID-19 Drug Candidate, Exhibits Potent In Vitro Antiviral Activity Against SARS-CoV-2
  https://www.biorxiv.org/content/10.1101/2020.10.29.352450v1.full

Global COVID-19 Cases and Mortality

An online tool tracking COVID-19 cases and mortality, both in the U.S. and globally, can be found on the Company’s website (http://www.ipharminc.com), and at the following link:
https://ipixcovid19tracker.com/

Alerts

Sign-up for Innovation Pharmaceuticals email alerts is available at:
http://www.ipharminc.com/email-alerts/

About Innovation Pharmaceuticals

Innovation Pharmaceuticals Inc. (IPIX) is a clinical stage biopharmaceutical company developing a world-class portfolio of innovative therapies addressing multiple areas of unmet medical need, including inflammatory diseases, cancer, infectious diseases, and dermatologic diseases. Brilacidin, a versatile compound with broad therapeutic potential, is in a new chemical class called defensin-mimetics. A Phase 2 trial of Brilacidin as an oral rinse for the prevention of Severe Oral Mucositis (SOM) in patients with Head and Neck Cancer, met its primary and secondary endpoints, including reducing the incidence of SOM. The Company plans to advance Brilacidin oral rinse into Phase 3 development, subject to available financial resources. Positive results were also observed in a Phase 2 Proof-of-Concept trial treating patients locally with Brilacidin for Ulcerative Proctitis/Ulcerative Proctosigmoiditis (UP/UPS). Brilacidin for UP/UPS was licensed to Alfasigma S.p.A. in July 2019. A Phase 2b trial of Brilacidin showed a single intravenous dose of the drug delivered comparable outcomes to a seven-day dosing regimen of the FDA-approved blockbuster daptomycin in treating Acute Bacterial Skin and Skin Structure Infection. Brilacidin, based on promising in vitro antiviral activity against SARS-CoV-2, is being evaluated as a potential treatment for COVID-19. Kevetrin is a novel anti-cancer drug shown to modulate p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations and has successfully completed a Phase 2 trial in Ovarian Cancer. More information is available on the Company website at www.IPharmInc.com.

Forward-Looking Statements: This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 including statements concerning future drug development plans, statements regarding the antiviral capabilities and therapeutic potential of Brilacidin and its impact on SARS-CoV-2 (COVID-19) and other coronaviruses, as well as obtaining government regulatory approvals to commence clinical testing. Other statements regarding future product developments, and markets, including with respect to specific indications, and any other statements which are other than statements of historical fact. These statements involve risks but not limited to risks related to conducting pre-clinical studies and clinical trials and seeking IND regulatory approval for Brilacidin and Kevetrin; that prior test results may not be replicated in future studies and trials, uncertainties and assumptions that could cause the Company’s actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. The Company has in some cases identified forward-looking statements by using words such as “anticipates,” “believes,” “hopes,” “estimates,” “looks,” “expects,” “plans,” “intends,” “goal,” “potential,” “may,” “suggest,” and similar expressions. Among other factors that could cause actual results to differ materially from those expressed in forward-looking statements are the Company’s need for, and the availability of, substantial capital in the future to fund its operations and research and development; including the amount and timing of the sale of shares of common stock under securities purchase agreements; the fact that the Company’s licensee(s) may not successfully complete pre-clinical or clinical testing and the Company will not receive milestone payments, or the fact that the Company’s compounds may not successfully complete pre-clinical or clinical testing, or be granted regulatory approval to be sold and marketed in the United States or elsewhere. A more complete description of these risk factors is included in the Company’s filings with the Securities and Exchange Commission. You should not place undue reliance on any forward-looking statements. The Company undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.

INVESTOR AND MEDIA CONTACTS


Innovation Pharmaceuticals Inc.


Leo Ehrlich
[email protected]

Identity management serves as essential technology for global car manufacturer to streamline customer experience

BELLEVUE, Wash., Nov. 16, 2020 (GLOBE NEWSWIRE) — Auth0, the identity platform for application teams, today announced that Subaru Corporation has chosen Auth0 to provide secure identity management for its newly launched online customer experience, “My Subaru.” Auth0’s secure and frictionless customer authentication experience serves as an essential element in Subaru’s leading approach to customer engagement and meeting the demands of shifting consumer behavior.

“My Subaru” was designed to support the corporation’s digital transformation efforts and appeal to the industry trend of consumers researching cars online more than ever before. Auth0 will serve as the primary authentication provider for Subaru, and will provide assistance in creating a foundational CRM and identity system for managing customer information in a secure manner. Driven by Japan’s Personal Information Protection Act—which requires companies to show how customer information is being received and managed—there is a widespread need for proper authentication and digital ID management solutions across the region. Auth0 will assist in compliance with this regulation.

For Subaru, customer experience could not exist without advanced security, and keeping customers’ personal information safeguarded was paramount. Auth0 was chosen for its ease-of-use, speed of deployment, and extensibility, together with its ability to provide multi-factor authentication (MFA), for even more secure digital engagement.

“Auth0 is a key factor in our ability to enhance our customers’ online experience, and also provides us with secure identity management. In the near future, we plan to launch a portal service compliant with the Personal Information Protection Act through Auth0’s technology,” said Atsushi Yasumuro, Chief of Business Innovation at Subaru Corporation. “Auth0 is exactly the kind of authentication solution that allows us to achieve Subaru’s vision of ‘Peace of mind & enjoyment,’ giving us the confidence that we are securing customers’ data while offering them the best experience possible.”

The automotive industry is facing a major transition in purchasing behavior, fueling Subaru’s considerable investment in its online offering. The company required an entirely new infrastructure and approach to managing customer information, focusing on integrated CRM software and an identity platform. Auth0 is a vital means for Subaru to build stronger relationships with customers, offer greater post-purchase service, and remain a leader in this highly competitive space.

“We’ve seen enormous momentum around digital transformation in the region. Combined with updated regulations around customer data management, it is more important than ever that identity management becomes a critical piece of any digital foundation,” said Eugenio Pace, co-founder and CEO of Auth0. “We are honored to work with Subaru on its industry-leading online offering, and look forward to merging identity security with their online presence into one seamless experience.”

With more than 550,000 users on its owner-oriented “My Subaru” application, Subaru’s goal is to improve consumer engagement and users’ before and after sales experience through universal identification, and the identity work in place now with Auth0 will help the company achieve its ambitious goals into the future.

About Auth0

Auth0 provides a platform to authenticate, authorize, and secure access for applications, devices, and users. Security and development teams rely on Auth0’s simplicity, extensibility, and expertise to make identity work for everyone. Safeguarding more than 4.5 billion login transactions each month, Auth0 secures identities so innovators can innovate, and empowers global enterprises to deliver trusted, superior digital experiences to their customers around the world.

For more information, visit https://auth0.com or follow @auth0 on Twitter.

Media Contacts:

Jessica Sealby
Auth0 PR Manager, APAC
[email protected]

 

The new


platform


will


offer consumers expanded choice, advances in mouthwatering taste and improved nutritional profiles

The brand’s juiciest burger


yet


will contain


35


% less saturated fat than 80/20 beef, while


its


most nutritious patty


to date


will register a full


55


% less saturated fat than 80/20 beef

Beyond Meat will unveil the new iterations of the Beyond Burger at an exclusive preview in Los Angeles Nov. 18-20

EL SEGUNDO, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) — Beyond Meat, Inc. (NASDAQ: BYND), a leader in plant-based meat, today announced the next step forward in cutting-edge innovation with the unveiling of two new versions of the Beyond Burger^® which are expected to launch nationwide in early 2021. A trifecta of taste, health and sustainability, the new iterations are designed to meet consumers’ growing demand for plant-based proteins that deliver on both taste and nutrition, while featuring an enhanced meaty flavor and the craveable taste consumers love, with an even better nutritional profile.

Similar to the range of nutritional options of beef currently available in the marketplace, the two versions are designed to offer more choice for consumers. The new Beyond Burgers will include the brand’s juiciest patty for the meatiest burger experience even as it delivers strong nutritional wins relative to 80/20 beef with 35% less saturated fat, as well as its most nutritious patty yet with 55% less saturated fat than 80/20 beef. Both new burgers will boast the same savory taste profile, have lower overall fat and fewer calories than 80/20 beef, and have B vitamins and minerals comparable to the micronutrient profile of beef.

“I am personally thrilled to introduce this new Beyond Burger platform as it speaks so clearly to what our brand and company stands for,” said Ethan Brown, CEO and Founder, Beyond Meat. “Our commitment is to provide consumers with absolutely delicious plant-based meats that are better for people and the planet, no sacrifice required. These new iterations deliver on this promise, and I am immensely proud of our team’s ability to make such strong advances in taste, juiciness and nutrition through our Rapid and Relentless Innovation program. Just as you can find different varieties of ground beef, consumers will now have more choice to satisfy their individual nutritional needs and preferences.” 

Rapid and Relentless Approach to Innovation


Beyond Meat’s best-in-class approach to creating cutting-edge innovations, coupled with a firm commitment to using only simple plant-based inputs and no bioengineered ingredients, has established the company as a category leader. The company introduced the Beyond Burger in 2016, revolutionizing the category as the first plant-based burger designed to look, cook and taste like animal meat and sold in the meat case. The new Beyond Burger iterations are the latest in a pipeline of new product offerings in 2020 following Beyond Breakfast Sausage^® Patties, Cookout Classic™, Beyond Meatballs™ and Beyond Breakfast Sausage Links. Beyond Meat sells products at approximately 122,000 retail and foodservice outlets in over 80 countries worldwide, including approximately 28,000 retail outlets in the U.S.

Commitment to Improving Human Health


Beyond Meat is committed to serving consumers’ growing demand for delicious, nutritious and sustainable protein with products that are simple and made from plants with no GMOs or bioengineered ingredients. Beyond Meat’s products do not contain many other elements, often found in animal protein, that have raised health or safety concerns, such as hormones, antibiotics, nitrates or heme iron, and the company is dedicated to supporting academic and scientific studies into the impacts of plant-based meats on health. The findings from a clinical study using Beyond Meat’s plant-based products were recently published in The American Journal of Clinical Nutrition. In the study conducted at Stanford University, researchers evaluated the impact of replacing animal-based meat with Beyond Meat’s plant-based meats over an 8-week period on cholesterol levels (including LDL), heart disease risk factors including TMAO levels, and body weight, and found improvement in key health metrics when participants replaced animal-based meat with Beyond Meat’s plant-based meat. The results provide yet another data point in a growing field of research about how plant-based meat can help people live healthier lives.

Meat with a Lighter Environmental Footprint


The results of the Stanford University study complement the results of the University of Michigan’s 2018 LCA which showed that the original Beyond Burger, compared to producing a ¼ lb. standard 80/20 beef burger, has 99% less impact on water scarcity, 93% less impact on land use, requires 46% less energy and generates 90% less greenhouse gas emissions. To illustrate these benefits, the company launched its What if We All Go Beyond? brand anthem, inviting consumers to see how over time through small changes, such as what you put at the center of your plate, there can be a meaningful collective impact on human health and the health of our planet.

Exclusive Preview: Be the First to Try It


Beyond Meat will host an exclusive preview in Los Angeles from Nov. 18-20 to unveil the new versions of the Beyond Burger. Bringing the Go Beyond^® brand mantra to life, the individualized, highly visual and immersive experience will include a first look and taste of the new Beyond Burgers. Reservations are available now via Resy, while supplies last. Follow Beyond Meat’s social channels for live updates from the event using #GoBeyond. The company expects to launch the new iterations of the Beyond Burger nationwide in early 2021.

About Beyond Meat

Beyond Meat, Inc. (NASDAQ: BYND) is one of the fastest growing food companies in the United States, offering a portfolio of revolutionary plant-based meats made from simple ingredients without GMOs, bioengineered ingredients, hormones, antibiotics, or cholesterol. Founded in 2009, Beyond Meat products are designed to have the same taste and texture as animal-based meat while being better for people and the planet. Beyond Meat’s brand commitment, Eat What You Love™, represents a strong belief that there is a better way to feed our future and that the positive choices we all make, no matter how small, can have a great impact on our personal health and the health of our planet. By shifting from animal-based meat to plant-based meat, we can positively impact four growing global issues: human health, climate change, constraints on natural resources and animal welfare. As of September 26, 2020, Beyond Meat had products available at approximately 122,000 retail and foodservice outlets in over 80 countries worldwide. Visit www.BeyondMeat.com and follow @BeyondMeat, #BeyondBurger and #GoBeyond on Facebook, Instagram and Twitter.

Forward Looking Statements

Certain statements in this release constitute “forward-looking statements.” These statements are based on management’s current opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results. These forward-looking statements are only predictions, not historical fact, and involve certain risks and uncertainties, as well as assumptions. Actual results, levels of activity, performance, achievements and events could differ materially from those stated, anticipated or implied by such forward-looking statements. While Beyond Meat believes that its assumptions are reasonable, it is very difficult to predict the impact of known factors, and, of course, it is impossible to anticipate all factors that could affect actual results. There are many risks and uncertainties that could cause actual results to differ materially from forward-looking statements made herein including, most prominently, the risks discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 filed with the U.S. Securities and Exchange Commission (“SEC”) on March 19, 2020, and the Company’s Quarterly Report on Form 10-Q for the quarter ended September 26, 2020 filed with the SEC on November 9, 2020, as well as other factors described from time to time in Beyond Meat’s filings with the SEC. Such forward-looking statements are made only as of the date of this release. Beyond Meat undertakes no obligation to publicly update or revise any forward-looking statement because of new information, future events or otherwise, except as otherwise required by law. If we do update one or more forward-looking statements, no inference should be made that we will make additional updates with respect to those or other forward-looking statements.

Media
Contact

Shira Zackai
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/0d98a9b4-5175-478e-9bbf-19883d4892c3

World’s Only Petascale Integrated AI Workgroup Server, Second-Gen DGX Station Packs Four NVIDIA A100 GPUs
, Debuts with up to 320GB of GPU Memory to Bring AI into Offices and Labs

SANTA CLARA, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) — SC20—NVIDIA today announced the NVIDIA DGX Station™ A100 — the world’s only petascale workgroup server. The second generation of the groundbreaking AI system, DGX Station A100 accelerates demanding machine learning and data science workloads for teams working in corporate offices, research facilities, labs or home offices everywhere.

Delivering 2.5 petaflops of AI performance, DGX Station A100 is the only workgroup server with four of the latest NVIDIA^® A100 Tensor Core GPUs fully interconnected with NVIDIA NVLink^®, providing up to 320GB of GPU memory to speed breakthroughs in enterprise data science and AI.

DGX Station A100 is also the only workgroup server that supports NVIDIA’s multi-instance GPU (MIG) technology. With MIG, a single DGX Station A100 provides up to 28 separate GPU instances to run parallel jobs and support multiple users without impacting system performance.

“DGX Station A100 brings AI out of the data center with a server-class system that can plug in anywhere,” said Charlie Boyle, vice president and general manager of DGX systems at NVIDIA. “Teams of data science and AI researchers can accelerate their work using the same software stack as NVIDIA DGX A100 systems, enabling them to easily scale from development to deployment.”

DGX Station Powers AI Innovation

Organizations around the world have adopted DGX Station to power AI and data science across industries such as education, financial services, government, healthcare and retail. These AI leaders include:

• BMW Group Production is using NVIDIA DGX Station to explore insights faster as they develop and deploy AI models that improve operations.
• DFKI, the German Research Center for Artificial Intelligence, is using DGX Station to build models that tackle critical challenges for society and industry, including computer vision systems that help emergency services respond rapidly to natural disasters.
• Lockheed Martin is using DGX Station to develop AI models that use sensor data and service logs to predict the need for maintenance to improve manufacturing uptime, increase safety for workers, and reduce operational costs.
• Pacific Northwest National Laboratory is using NVIDIA DGX Station to conduct federally funded research in support of national security. Focused on technological innovation in energy resiliency and national security, PNNL is a leading U.S. HPC center for scientific discovery, energy resilience, chemistry, Earth science and data analytics.
• NTT Docomo, Japan’s leading mobile operator with over 79 million subscribers, uses DGX Station to develop innovative AI-driven services such as its image recognition solution.

An AI Supercomputer Anywhere

While DGX Station A100 does not require data-center-grade power or cooling, it is a server-class system that features the same remote management capabilities as NVIDIA DGX A100 data center systems. System administrators can easily perform any management tasks over a remote connection when data scientists and researchers are working at home or in labs.

DGX Station A100 is available with four 80GB or 40GB NVIDIA A100 Tensor Core GPUs, providing options for data science and AI research teams to select a system according to their unique workloads and budgets.

To power complex conversational AI models like BERT Large inference, DGX Station A100 is more than 4x faster than the previous generation DGX Station. It delivers nearly a 3x performance boost for BERT Large AI training.

Doubling Down on GPU Memory for AI, HPC

For advanced data center workloads, DGX A100 systems will be available with the new NVIDIA A100 80GB GPUs, doubling GPU memory capacity to 640GB per system to enable AI teams to boost accuracy with larger datasets and models.

The new NVIDIA DGX A100 640GB systems can also be integrated into the NVIDIA DGX SuperPOD™ Solution for Enterprise, allowing organizations to build, train and deploy massive AI models on turnkey AI supercomputers available in units of 20 DGX A100 systems.

The first installments of NVIDIA DGX SuperPOD systems with DGX A100 640GB will include the Cambridge-1 supercomputer being installed in the U.K. to supercharge healthcare research, as well as the new University of Florida HiPerGator AI supercomputer that will power AI-infused discovery across the Sunshine State.

Availability

NVIDIA DGX Station A100 and NVIDIA DGX A100 640GB systems will be available this quarter through NVIDIA Partner Network resellers worldwide. An upgrade option is available for NVIDIA DGX A100 320GB customers.

Learn more about DGX Station A100 in the live NVIDIA SC20 Special Address at 3 p.m. PT today, and register for the Learn to Build Bigger AI, Faster with DGX Station webinar, on Wednesday, Dec. 2.

About NVIDIA

NVIDIA’s (NASDAQ: NVDA) invention of the GPU in 1999 sparked the growth of the PC gaming market, redefined modern computer graphics and revolutionized parallel computing. More recently, GPU deep learning ignited modern AI — the next era of computing — with the GPU acting as the brain of computers, robots and self-driving cars that can perceive and understand the world. More information at https://nvidianews.nvidia.com/.

For further information, contact:

Shannon McPhee
NVIDIA Corporation
+1-310-920-9642
[email protected]

Certain statements in this press release including, but not limited to, statements as to: the benefits, performance, features and abilities of the NVIDIA DGX Station A100; DGX Station A100 bringing AI out of the data center and under desks everywhere, its installation rate, it accelerating the work of millions of data scientists and AI researchers, and its scalability; the companies using NVIDIA DGX Stations and how they are using them; the size and growth of AI models and DGX Station A100 systems helping to address this; DGX A100 systems being integrated into the NVIDIA DGX SuperPOD Solution for Enterprise and what it enables; the first installments of NVIDIA DGX SuperPOD systems; and the price and availability of NVIDIA DGX Station A100 systems are forward-looking statements that are subject to risks and uncertainties that could cause results to be materially different than expectations. Important factors that could cause actual results to differ materially include: global economic conditions; our reliance on third parties to manufacture, assemble, package and test our products; the impact of technological development and competition; development of new products and technologies or enhancements to our existing product and technologies; market acceptance of our products or our partners’ products; design, manufacturing or software defects; changes in consumer preferences or demands; changes in industry standards and interfaces; unexpected loss of performance of our products or technologies when integrated into systems; as well as other factors detailed from time to time in the most recent reports NVIDIA files with the Securities and Exchange Commission, or SEC, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q. Copies of reports filed with the SEC are posted on the company’s website and are available from NVIDIA without charge. These forward-looking statements are not guarantees of future performance and speak only as of the date hereof, and, except as required by law, NVIDIA disclaims any obligation to update these forward-looking statements to reflect future events or circumstances.

© 2020 NVIDIA Corporation. All rights reserved. NVIDIA, the NVIDIA logo, NVIDIA DGX Station, NVIDIA DGX SuperPOD and NVLink are trademarks and/or registered trademarks of NVIDIA Corporation in the U.S. and other countries. All other trademarks and copyrights are the property of their respective owners. Features, pricing, availability and specifications are subject to change without notice.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6d88fc00-86ed-4cc9-9e99-7a7abfdd3a20

CAMBRIDGE, Mass., Nov. 16, 2020 (GLOBE NEWSWIRE) — Squadle, a technology company that enables multi-unit operators to simplify complex operations and streamline food safety, today announced that McBee Enterprises, which operates a large McDonald’s restaurant franchise across Massachusetts’ South Shore and on Cape Cod, has implemented Squadle Digital Checklist across all its stores. Leveraging Squadle’s Digital Food Safety and Digital Shift Management products, McBee Enterprises has been able to effortlessly keep stores in compliance with mandated food safety regulations.

Read the customer story: McDonald’s Franchisee McBee Enterprises Streamlines Food Safety Compliance with Squadle

Digital food safety checklists record up-to-the-minute completion rates while personalized dashboards send text and email alerts for a real-time pulse on the activity and compliance in each store. At McBee Enterprises, store managers and supervisors can verify food safety compliance remotely and in real time to ensure that all critical safety standards have been met. Overall, the introduction of Squadle’s products has enabled restaurant staff to save time on food safety and compliance tasks, and instead focus that time on customers and Covid protocols.

“Once the daily food safety checks are done, supervisors can audit results on a daily basis. The supervisors no longer have to physically visit restaurants and review paper pages to make sure food safety checks are done,” said Mark McBee, Owner and Operator of McBee Enterprises.

With Squadle Checklists, McBee Enterprises is seeing the following benefits:

Time savings through efficient operations: Saving 90 minutes a day in man hours through Squadle’s food safety checks.

Fewer people needed for food safety: Food safety checks now require one employee rather than three. This time saved is reallocated to more customer-facing tasks.

McBee Enterprises also is taking advantage of the Squadle Shift Management Checklists with its COVID-specific requirements to maintain safety standards. Squadle Shift Management is a cloud-based, digital solution where standard operating procedures are displayed with a daily completion percentage for each location, providing a benchmark for operational consistency.

Squadle is a customizable operations platform that restaurants, convenience stores and retailers can use to fully digitize their paper-based manager playbooks, checklists, and compliance forms to ensure higher completion rates, leading to more efficient operations and better customer experiences.

For more information on the Squadle Digital Checklists, visit https://squadle.com/digital-food-safety.

About Squadle

Squadle is a technology company committed to delivering flexible, user-friendly applications that enable multi-unit operators, convenience stores, and retailers to simplify complex operations and streamline food safety. By combining its proprietary digital checklists, patented sensor automation, and machine vision technology with its customer first approach, Squadle delivers intuitive, out-of-the-box ready products. Squadle’s customers operate tens of thousands of locations worldwide and include the largest and most respected brands in their industries. Learn more at www.squadle.com.

Media Contact:
  
Derek Stangle, Squadle, Inc.
[email protected]
https://www.squadle.com